Update on Investigational Alzheimer's Drug

Author: Susan Farley

Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD). The researchers studying the drug, Memryte, observed positive effects among women but not among men.

The findings have prompted Voyager to focus on developing the drug to treat AD specifically for women.